Cambridge Bioscience Corp.

FDA Regulatory Profile

Cambridge Bioscience Corp. appears in FDA public data with 0 recalls, 5 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on March 15, 1989.

Summary

Total Recalls
0
510(k) Clearances
5
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K890281HUMAN LYME EIA FOR THE DETECT OF ANTIBODIESMarch 15, 1989
K881894ADENOCLONE(R)-TYPE 40/41 EIA DIAGNOSTIC TEST (48)July 8, 1988
K873082ADENOCLONE(TM)-EIA ADENOVIRUS ANTIGEN TESTFebruary 24, 1988
K873312ADENOCLONE(TM)-IFA, ADENOVIRUS ANTIGEN TESTFebruary 24, 1988
K852969ROTACLONE ROTAVIRUS DIAGNOSTIC KITNovember 5, 1985